Cross-linked hyaluronic acid gel occlusive device for the treatment of dry eye syndrome
John P Fezza Center for Sight, Sarasota, FL, USA Purpose: A new cross-linked hyaluronic acid (xlHA) gel occlusive device was assessed for safety and efficacy in the treatment of dry eyes.Methods: This was an institutional review board-approved, single-site, open-label, prospective study to assess...
Main Author: | Fezza JP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-11-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/cross-linked-hyaluronic-acid-gel-occlusive-device-for-the-treatment-of-peer-reviewed-article-OPTH |
Similar Items
-
Management of punctal occlusion post-viral conjunctivitis
by: Fawwaz A. Al-Sarayra, et al.
Published: (2015-05-01) -
Botulinum neurotoxin type A versus punctal plug insertion in the management of dry eye disease
by: Amal A Bukhari
Published: (2014-01-01) -
Experimental study of degradable polylactic acid punctal plugs
by: Zhi-Yong Wu
Published: (2013-12-01) -
A retrospective analysis of dry eye interventions during the first postoperative year of patients undergoing LASIK versus PRK
by: Ribeiro, Pamela Bastos
Published: (2020) -
A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome
by: Yun-Jung Yang, et al.
Published: (2021-03-01)